首页> 外文OA文献 >Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project

【2h】

Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project

机译：六个月的六个月佐剂Folfox或Capox用于高风险阶段II和III阶段结肠癌患者：Hellenic肿瘤研究组（Horg）参与佐剂化疗的国际持续时间评估（IDEA）项目的疗效结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
J. Souglakos; I. Boukovinas; S. Kakolyris; S. Xynogalos; N. Ziras; A. Athanasiadis; N. Androulakis; A. Christopoulou; M. Vaslamatzis; A. Ardavanis; C. Emmanouilides; I. Bompolaki; C. Kourousis; P. Makrantonakis; C. Christofyllakis; E. Athanasiadis; N. Kentepozidis; A. Karampeazis; U. Katopodi; A. Anagnosopoulos; G. Papadopoulos; E. Prinarakis; A. Kalisperi; D. Mavroudis; V. Georgoulias;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status [J] . Thierry André, Timothy Iveson, Roberto Labianca, Current Colorectal Cancer Reports . 2013,第3期

机译：IDEA（国际辅助化疗持续时间评估）合作：研究III期结肠癌患者用FOLFOX（FOLFOX4或改良的FOLFOX6）或XELOX（3个月和6个月）方案的辅助治疗持续时间的III期试验的前瞻性联合分析：试验设计与现状
2. Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial [J] . Andre Thierry, Vernerey Dewi, Mineur Laurent, Journal of Clinical Oncology . 2018,第15期

机译：三个与6个月的oxaliplatin辅助化疗为III阶段结肠癌患者：无病的生存结果来自随机，开放标签，佐剂国际持续时间评估（想法）法国，第三阶段试验
3. Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for PatientsWith Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial (vol 36, pg 1469, 2018) [J] . Andre Journal of Clinical Oncology . 2018,第18期

机译：三个与6个月的oxaliplatin为基于患者的辅助化疗，患者患者III阶段III结肠癌：无病的生存结果来自随机，开放标签，国际持续时间评估的佐剂（想法）法国，III期试验（Vol 36，PG 1469， 2018年）
4. Adjuvant Chemotherapy Should Not Routinely Be Recommended to Patients with Stage II Colon Cancers that Manifest Microsatellite Instability [C] . Sigurdis Haraldsdottir, Richard M. Goldberg Gastrointestinal Cancers Symposium . 2014

机译：不应常规向患有阶段结肠癌的患者常规的辅助化学疗法，表明微卫星不稳定性
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status [O] . Thierry André, Timothy Iveson, Roberto Labianca, -1

机译：IDEA（国际辅助化疗持续时间评估）合作：III期试验的前瞻性联合分析研究针对III期结肠癌患者的FOLFOX（FOLFOX4或改良的FOLFOX6）或XELOX（3个月至6个月）方案的辅助治疗的持续时间的III期试验：试验设计与现状
7. The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status [O] . Thierry André, null null, Timothy Iveson, 2013

机译：IDEA（国际辅助化疗持续时间评估）合作：III期试验的前瞻性联合分析，研究针对III期结肠癌患者的FOLFOX（FOLFOX4或改良的FOLFOX6）或XELOX（3个月至6个月）方案的辅助治疗的持续时间的III期试验：试验设计与现状

Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project

著录项

引文网络

相似文献

相关主题

期刊订阅